Surgeons, Urologist
6 years of experience

Accepting new patients
1250 S Cedar Crest Blvd
Ste 210
Allentown, PA 18103
610-402-6986
Locations and availability (11)

Education ?

Medical School Score
George Washington University (2004)
  • Currently 2 of 4 apples

Awards & Distinctions ?

Associations
Society of Urologic Oncology
American Urological Association

Affiliations ?

Dr. Canter is affiliated with 7 hospitals.

Hospital Affilations

Score

Rankings

  • Albert Einstein Medical Center
    5501 Old York Rd, Philadelphia, PA 19141
    • Currently 3 of 4 crosses
    Top 50%
  • Montgomery Hospital XXXXX
    900 E Fornance St, Norristown, PA 19401
    • Currently 3 of 4 crosses
    Top 50%
  • Emory University Hospital
    Urology
    1364 Clifton Rd Ne, Atlanta, GA 30322
    • Currently 2 of 4 crosses
  • Fox Chase Cancer Center
    333 Cottman Ave, Philadelphia, PA 19111
  • Mossrehab & Albert Einstein Med Ctr
    60 Township Line Rd, Elkins Park, PA 19027
  • Elkins Park Hospital
    60 Township Line Rd, Elkins Park, PA 19027
  • Atlanta Veterans Affairs Medical Center
    1670 Clairmont Rd, Decatur, GA 30033
  • Publications & Research

    Dr. Canter has contributed to 13 publications.
    Title Small Renal Masses Progressing to Metastases Under Active Surveillance: a Systematic Review and Pooled Analysis.
    Date April 2012
    Journal Cancer
    Excerpt

    The authors systematically reviewed the literature and conducted a pooled analysis of studies on small renal masses who underwent active surveillance to identify the risk progression and the characteristics associated with metastases.

    Title Delayed Proximal Ureteric Stricture Formation After Complex Partial Nephrectomy.
    Date March 2012
    Journal Bju International
    Excerpt

    •  To report and review our incidence of delayed ureteric stricture (US) after complex nephron-sparing surgery (NSS).

    Title Anatomic Features of Enhancing Renal Masses Predict Malignant and High-grade Pathology: a Preoperative Nomogram Using the Renal Nephrometry Score.
    Date October 2011
    Journal European Urology
    Excerpt

    Counseling patients with enhancing renal mass currently occurs in the context of significant uncertainty regarding tumor pathology.

    Title Docetaxel-mediated Apoptosis in Myeloid Progenitor Tf-1 Cells is Mitigated by Zinc: Potential Implication for Prostate Cancer Therapy.
    Date October 2011
    Journal The Prostate
    Excerpt

    Docetaxel-based combination chemotherapy is approved by the FDA for the treatment of metastatic castration-resistant prostate cancer. Unfortunately, docetaxel's efficacy is significantly limited by its considerable toxicity on hematopoietic progenitor cells, thus necessitating dose reduction or even discontinuation of the chemotherapy. Induction of pre-mitotic arrest protects cells against docetaxel-mediated toxicity and affords therapeutic opportunities.

    Title Routine Adrenalectomy is Unnecessary During Surgery for Large And/or Upper Pole Renal Tumors when the Adrenal Gland is Radiographically Normal.
    Date May 2011
    Journal The Journal of Urology
    Excerpt

    Concurrent adrenalectomy during renal surgery for renal cell carcinoma was once routine. More recent data suggest that adrenalectomy should be reserved for tumors 7 cm or greater, particularly those involving the upper pole. We evaluated the radiographic and pathological incidence of adrenal involvement in patients undergoing renal surgery for renal cell carcinoma 7 cm or greater.

    Title Metanephric Adenofibroma: Robotic Partial Nephrectomy of a Large Wilms' Tumor Variant.
    Date November 2010
    Journal The Canadian Journal of Urology
    Excerpt

    A case of the rare, benign, Wilms' tumor (WT) variant, metanephric adenofibroma (MAF), is presented.

    Title Defining Pathological Variables to Predict Biochemical Failure in Patients with Positive Surgical Margins at Radical Prostatectomy: Implications for Adjuvant Radiotherapy.
    Date June 2010
    Journal Bju International
    Excerpt

    To evaluate the utility of estimated tumour volume, number of positive surgical margins (PSMs), and margin location for predicting biochemical failure in patients with PSM, in an attempt to better risk-stratify the heterogeneous group of patients at high risk of biochemical failure after radical prostatectomy (RP) for prostate cancer.

    Title Does Race Affect Postoperative Outcomes in Patients with Low-risk Prostate Cancer Who Undergo Radical Prostatectomy?
    Date April 2009
    Journal Urology
    Excerpt

    To assess the magnitude of racial disparities in prostate cancer outcomes following radical prostatectomy for low-risk prostate cancer.

    Title Initial Experience with Laparoscopic Transvesical Ureteral Reimplantation at the Children's Hospital of Philadelphia.
    Date January 2007
    Journal The Journal of Urology
    Excerpt

    PURPOSE: Laparoscopic transvesical ureteral reimplantation with or without robotic assisted surgical devices is being developed as an alternative to open surgery. We review our experience with laparoscopic transvesical ureteral reimplantation. MATERIALS AND METHODS: A total of 32 patients underwent laparoscopic transvesical reimplantation by the same surgeon. Of the patients 5 had primary obstructing megaureters and 27 had vesicoureteral reflux. Transvesical laparoscopic cross-trigonal ureteral reimplantation was performed in patients with reflux, and a Glenn-Anderson reimplantation was used in patients with a primary obstructing megaureter. A pure laparoscopic approach using two 3 mm working ports and a 5 mm camera port was used. RESULTS: The operative success rates were 92.6% and 80% for vesicoureteral reflux and primary obstructing megaureter cases, respectively. Complications included a postoperative urinary leak in 4 patients (12.5%) and ureteral stricture at the neoureterovesical anastomosis in 2 (6.3%). All but 1 complication occurred in patients 2 years or younger with bladder capacity less than 130 cc. CONCLUSIONS: Laparoscopic intravesical reimplantation is in its infancy and appears to have higher complication rates in young patients with small bladder capacity.

    Title The Clinical and Pathological History of Prostate Cancer Progression in Men with a Prior History of High Grade Prostatic Intraepithelial Neoplasia.
    Date
    Journal The Canadian Journal of Urology
    Excerpt

    OBJECTIVES: The natural history of high grade prostatic intraepithelial neoplasia (HGPIN) is incompletely understood limiting evidence based recommendations regarding screening and repeat biopsy intervals. Our objective was to evaluate the natural history of HGPIN to better assess the time frame to disease progression and the pathological findings at the time of progression to cancer. METHODS AND MATERIALS: We retrospectively reviewed 74 consecutive patients with an initial diagnosis of HGPIN. The number and timing of all biopsies leading to the diagnosis of cancer were assessed. Clinical and pathological features of those patients with eventual disease progression were evaluated. RESULTS: The mean number of biopsies performed before subsequent cancer diagnosis was 5 (range: 3-13). The mean time to the diagnosis of cancer was 29 months (range: 7-83). Men with a history of HGPIN had lower percent positive biopsies at the time of cancer diagnosis (p < 0.001) and smaller volume tumors on final pathology (p = 0.041) compared to men without a history of HGPIN. CONCLUSIONS: Patients with an initial diagnosis of HGPIN on transrectal ultrasound (TRUS) guided biopsy progressed to cancer at a mean of 29 months. The vast majority of patients that progressed to prostate cancer had low volume disease at the time of diagnosis and definitive treatment. Our data indicate the importance of re-evaluation in HGPIN patients and suggest a trend toward low volume disease in carefully followed patients. Prospective data is warranted to adequately define an evidence based biopsy regimen in men with HGPIN.

    Title Percutaneous Vs Surgical Cryoablation of the Small Renal Mass: is Efficacy Compromised?
    Date
    Journal Bju International
    Excerpt

    Study Type - Therapy (systematic review)
Level of Evidence 1b OBJECTIVE: To review and analyse the cumulative literature to compare surgical and percutaneous cryoablation of small renal masses (SRMs). METHODS: A MEDLINE search was performed (1966 to February 2010) of the published literature in which cryoablation was used as therapy for localized renal masses. Residual disease was defined as persistent enhancement on the first post-ablation imaging study, while recurrent disease was defined as enhancement after an initially negative postoperative imaging study, consistent with the consensus definition by the Working Group on Image-Guided Tumor Ablation. Data were collated and analysed using the two-sample Mann-Whitney test and random-effects Poisson regression, where appropriate. RESULTS: In all, 42 studies, representing 1447 lesions treated by surgical (n= 28) or percutaneous (n= 14) cryoablation were pooled and analysed. No significant differences were detected between approaches regarding patient age (median 67 vs 66 years, P= 0.55), tumour size (median 2.6 vs 2.7 cm, P= 0.24),or duration of follow-up (median 14.9 vs 13.3 months, P= 0.40). Differences in rates of unknown pathology also failed to reach statistical significance (14 vs 21%, P= 0.76). The difference in the rate of residual tumour was not statistically different (0.033 vs 0.046, P= 0.25), nor was the rate of recurrent tumour (0.008 vs 0.009, P= 0.44). The reported rate of metastases was negligible in both groups, precluding statistical analysis. CONCLUSIONS: Cryoablation has shown acceptable short-term oncological results as a viable strategy for SRMs. Analysis of the cumulative literature to date shows that surgical and percutaneous cryoablation have similar oncological outcomes.

    Title Impact of Adjuvant Chemotherapy on Patients with Lymph Node Metastasis at the Time of Radical Cystectomy.
    Date
    Journal The Canadian Journal of Urology
    Excerpt

    Radical cystectomy (RC) remains the gold standard treatment for patients with muscle-invasive bladder cancer. Unfortunately, a significant proportion of patients will have lymph node involvement at the time of RC. We set out to determine the impact of adjuvant cisplatin-based chemotherapy (AC) in a cohort of lymph node positive patients following RC.

    Title Endorectal T2-weighted Mri Does Not Differentiate Between Favorable and Adverse Pathologic Features in Men with Prostate Cancer Who Would Qualify for Active Surveillance.
    Date
    Journal Urologic Oncology
    Excerpt

    With the increased diagnosis of low grade, low volume, potentially non-lethal disease, active surveillance (AS) has become an increasingly popular alternative for select men with low-risk prostate cancer. The absence of precise clinical staging modalities currently makes it difficult to predict which patients are most appropriate for AS. The goal of our study was to evaluate the ability of endorectal MRI (eMRI) to predict adverse pathologic features in patients who would otherwise qualify for an AS program.


    Similar doctors nearby

    Dr. Clifford Georges

    Surgery
    3 years experience
    Allentown, PA

    Dr. Barry Berger

    Orthopaedic Surgery
    18 years experience
    Allentown, PA

    Dr. Clarissa Liew

    Neurology
    19 years experience
    Allentown, PA

    Dr. Scott Sexton

    Orthopaedic Surgery
    10 years experience
    Allentown, PA

    Dr. Angelo Baccala

    Anesthesiology
    8 years experience
    Allentown, PA

    Dr. Michael Moritz

    Orthopaedic Surgery
    30 years experience
    Allentown, PA
    Search All Similar Doctors